A donor’s sperm, unknowingly carrying a mutation of the TP53 gene linked to Li-Fraumeni syndrome, has been used to conceive nearly 200 children across Europe, raising concerns about their increased cancer risk, particularly childhood cancers. Investigations revealed that some of these children have already developed cancer, prompting calls for stricter genetic screening of sperm donors and limits on the number of children conceived from a single donor. While UK regulations restrict donors to 10 families, other countries have more lenient rules, leading to over 50 children from this donor in Belgium alone. Health authorities emphasize the need for better oversight in fertility treatments to prevent such situations in the future.
